通过SPA功能化的磁纳米粒子在侧流免疫试验中的定向标签来提高灵敏度的检测
Penghua Zhao1,2, Yaping Li1,2, Qing Feng1,2
1Research Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Mikrochimica acta
|September 8, 2025
概括
本研究介绍了一种使用磁纳米颗粒的指导性标签策略,用于在临床检测 (POCT) 中增强检测Mycoplasma pneumoniae. 该方法显著提高了诊断非典型肺炎的灵敏度和准确性.
科学领域:
- 生物技术是生物技术.
- 纳米技术纳米技术
- 医学诊断 医学诊断 医学诊断
背景情况:
- 菌性肺炎引起非典型的肺炎,需要快速的护理点诊断 (POCT).
- 侧流免疫试验 (LFIA) 对POCT有希望,但由于探针亲和力和矩阵干扰,其灵敏度受到限制.
研究的目的:
- 开发使用磁纳米颗粒 (MNP) 的指导性标签策略,以提高LFIA对Mycoplasma pneumoniae检测的敏感性.
- 改善抗体定向,并使磁性丰富成为更准确的POCT.
主要方法:
- 合成的葡萄球菌蛋白A (SPA) 功能化的MNP用于通过Fc结合的定向抗体结合.
- 利用聚合-沉交叉连接用于SPA-MNP合成,减少固态障碍.
- 实施磁性丰富,以进一步提高灵敏度和检测极限 (LOD).
主要成果:
- 与随机探测器相比,定向探测器显示出增强的稳定性,特异性和结合亲和力.
- 定向标签方法实现了较低的检测极限 (10^5 CFU·mL^-1) 比随机探测器 (10^6 CFU·mL^-1).
- 磁性丰富进一步提高了对10^4 CFU/mL的灵敏度,LOD为0.668 × 10^4 CFU/mL. 临床评估显示,与qPCR的一致性为88.5%.
结论:
- 开发的带有磁性丰富的定向标签平台克服了LFIA在低丰度病原体检测中的灵敏度障碍.
- 该战略为各种传染病提供了高性能POCT的通用设计.
- 该方法显示了用于准确和快速诊断非典型肺炎的显著潜力.
更多相关视频
07:13Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
2.1K
09:58Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
Published on: June 23, 2022
2.6K
相关概念视频
Labeling DNA Probes
9.3K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
9.3K
Enzyme-Linked Immunosorbent Assay
17.3K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
17.3K
